Gelatinolytic activity in tracheal epithelial lining fluid and in blood from horses with chronic obstructive pulmonary disease.

Am J Vet Res

Department of Clinical Veterinary Sciences, Faculty of Veterinary Medicine, Helsinki University, Finland.

Published: July 1998

Objectives: To determine whether gelatinolytic activity in tracheal epithelial lining fluid (TELF), blood neutrophils, and blood lymphocytes from horses was metalloprotease activity, and to compare, for healthy horses and horses with chronic obstructive pulmonary disease, gelatinolytic activity in neutrophils, lymphocytes, and serum with activity in TELF.

Animals: 7 horses with chronic obstructive pulmonary disease (COPD) and 4 healthy control horses.

Procedure: Neutrophils and lymphocytes were obtained by means of Percoll separation. Zymography was used to detect gelatinolytic activity; EDTA inhibition and 4-aminophenyl mercuric acetate activation were used to verify that gelatinolytic activity was metalloprotease activity.

Results: Gelatinolytic activity was significantly higher in TELF from horses with COPD than in TELF from healthy horses. For all samples, EDTA inhibited and APMA activated gelatinolytic activity. Gelatinolytic activity of neutrophils, lymphocytes, and serum was not significantly different between healthy horses and horses with COPD.

Conclusions: Results suggested that gelatinolytic activity in TELF from horses is metalloprotease activity. Gelatinolytic activity is increased in TELF from horses with COPD, but not in serum, neutrophils, or lymphocytes. Neutrophils and lymphocytes are possible sources of gelatinolytic activity in TELF.

Clinical Relevance: Measurements of serum, blood neutrophil, or blood lymphocyte gelatinolytic activity were of little value in distinguishing horses with COPD from healthy horses.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gelatinolytic activity
48
neutrophils lymphocytes
20
healthy horses
16
activity
14
horses
13
gelatinolytic
12
horses chronic
12
chronic obstructive
12
obstructive pulmonary
12
pulmonary disease
12

Similar Publications

Loss of hepatocyte growth factor activator inhibitor type 1 (HAI-1) upregulates MMP-9 expression and induces degradation of the epidermal basement membrane.

Hum Cell

December 2024

Section of Oncopathology and Morphological Pathology, Department of Pathology, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miazaki, 889-1692, Japan.

Hepatocyte growth factor activator inhibitor type 1 (HAI-1), which is encoded by the SPINT1 gene, is a membrane-associated serine proteinase inhibitor abundantly expressed in epithelial tissues. We had previously demonstrated that HAI-1 is critical for placental development, epidermal keratinization, and maintenance of keratinocyte morphology by regulating cognate proteases, matriptase and prostasin. After performing ultrastructural analysis of Spint1-deleted skin tissues, our results showed that Spint1-deleted epidermis exhibited partially disrupted epidermal basement-membrane structures.

View Article and Find Full Text PDF

MMP inhibition, marginal integrity and cytotoxicity of zinc-releasing GIC.

J Dent

December 2024

Department of Cariology and Operative Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Objectives: The degradation of the restorative-dentin interface due to endogenous dentin enzymes, such as matrix metalloproteinases (MMPs), is a significant issue that accelerates the deterioration of the dentin matrix and leads to the failure of restorative treatments. Caredyne Restore (CR), a novel glass ionomer cement (GIC) with zinc ions in its formulation, represents the latest effort to mitigate this issue. This investigation aimed to evaluate the MMPs inhibitory effect, marginal integrity, and cytotoxicity of CR compared to a conventional GIC, Fuji IX (FIX).

View Article and Find Full Text PDF

Gelatinolytic activity in dentin upon adhesive treatment.

Sci Rep

November 2024

Department of Oral Health Sciences, BIOMAT & UZ Leuven, Dentistry, KU Leuven, Kapucijnenvoer 7, 3000, Leuven, Belgium.

In this multi-parameter study, the effect of diverse factors related to adhesive application on the activation of host-derived gelatinases was investigated by gelatin zymography, in-situ zymography, fluorogenic DQ-gelatin assay and micro-tensile bond-strength (μTBS) testing. Gelatin zymography disclosed the presence of gelatinases in phosphoric acid-etched dentin powder, while two gold-standard adhesives generated no measurable MMP activation. In-situ zymography revealed that the interfacial gelatinolytic activity from specimens treated with the two adhesives appeared similar as that of the EDTA negative control, indicating no detectable gelatinases were activated upon adhesive treatment.

View Article and Find Full Text PDF

A simple method to determine proteolytic activity of snake venoms.

Toxicon

November 2024

Laboratorio de Toxinopatología, Departamento de Patología, Facultad de Medicina, José E. Uriburu 950, 5(to) piso (1114), Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto Nacional de Producción de Biológicos I.N.P.B. - A.N.L.I.S. ''Dr. Carlos G. Malbrán'', Ministerio de Salud, Av. Vélez Sarsfield 563 (1282), Buenos Aires, Argentina; Área Investigación y Desarrollo - Venenos, Aracnario-Serpentario. Instituto Nacional de Producción de Biológicos, A.N.L.I.S. "Dr. Carlos G. Malbrán", Av. Velez Sarsfield 563 (1282). Buenos Aires, Argentina. Electronic address:

In this work, we describe an easy, simple, and cost-effective method to assess the proteolytic activity of snake venoms. The method is based on measuring the hydrolytic halo formed by gelatin radial hydrolysis following the incubation of venoms on a solid gelatin-agarose plate. Venoms from Bothrops (B.

View Article and Find Full Text PDF

Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers.

Int J Mol Sci

October 2024

Grupo de Investigación Cánceres de Origen Epitelial, Departamento de Biología de Sistemas, Campus Científico-Tecnológico, Universidad de Alcalá, 28805 Madrid, Spain.

Article Synopsis
  • The study investigates the combined effects of GHRH-R antagonist MIA-690 and EGFR inhibitor Gefitinib on advanced prostate cancer cells, as treating castration-resistant prostate cancer (CRPC) is challenging due to drug resistance.
  • Findings show that this combination therapy significantly reduces cell viability, adhesion, and metalloprotease activity, while also causing cell cycle arrest in prostate cancer PC-3 cells.
  • In vivo results from athymic nude mice confirm that the combined treatment is more effective against tumors than using either drug alone, by disrupting the interaction between GHRH-R and EGFR pathways.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!